Zacks Research Weighs in on Nutrien’s Q2 Earnings (NYSE:NTR)

Nutrien Ltd. (NYSE:NTR) – Investment analysts at Zacks Research lifted their Q2 2027 earnings per share estimates for Nutrien in a research report issued to clients and investors on Wednesday, April 15th. Zacks Research analyst Team now forecasts that the company will post earnings of $1.87 per share for the quarter, up from their previous forecast of $1.84. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Nutrien’s current full-year earnings is $3.72 per share. Zacks Research also issued estimates for Nutrien’s Q3 2027 earnings at $0.93 EPS, Q1 2028 earnings at $0.64 EPS and FY2028 earnings at $4.59 EPS.

Several other analysts have also issued reports on NTR. TD Securities boosted their target price on Nutrien from $80.00 to $81.00 and gave the company a “buy” rating in a research note on Tuesday, February 17th. JPMorgan Chase & Co. boosted their target price on Nutrien from $68.00 to $78.00 and gave the company an “overweight” rating in a research note on Friday, February 20th. UBS Group cut Nutrien from a “neutral” rating to a “sell” rating and lifted their price target for the company from $63.00 to $67.00 in a research report on Thursday, March 26th. Royal Bank Of Canada lifted their price target on Nutrien from $80.00 to $85.00 and gave the company an “outperform” rating in a research report on Tuesday, April 7th. Finally, BMO Capital Markets lifted their price target on Nutrien from $85.00 to $90.00 and gave the company an “outperform” rating in a research report on Wednesday, March 18th. Ten investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $79.65.

Nutrien Stock Performance

Shares of NTR opened at $73.36 on Thursday. The firm has a market cap of $35.29 billion, a PE ratio of 15.74 and a beta of 0.69. The stock’s fifty day moving average price is $74.35 and its two-hundred day moving average price is $65.55. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.34 and a quick ratio of 0.70. Nutrien has a 1 year low of $51.98 and a 1 year high of $85.36.

Nutrien (NYSE:NTR) last issued its earnings results on Wednesday, February 18th. The company reported $0.83 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.87 by ($0.04). The firm had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.26 billion. Nutrien had a net margin of 8.43% and a return on equity of 8.41%. The business’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.31 earnings per share.

Nutrien Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be given a $0.55 dividend. This represents a $2.20 annualized dividend and a dividend yield of 3.0%. This is a boost from Nutrien’s previous quarterly dividend of $0.55. The ex-dividend date is Tuesday, March 31st. Nutrien’s dividend payout ratio (DPR) is presently 47.21%.

Hedge Funds Weigh In On Nutrien

Several hedge funds have recently made changes to their positions in the stock. Guggenheim Capital LLC raised its stake in Nutrien by 2.2% in the fourth quarter. Guggenheim Capital LLC now owns 6,628 shares of the company’s stock worth $409,000 after buying an additional 145 shares in the last quarter. Minot DeBlois Advisors LLC raised its stake in Nutrien by 1.8% in the fourth quarter. Minot DeBlois Advisors LLC now owns 9,032 shares of the company’s stock worth $557,000 after buying an additional 164 shares in the last quarter. Smith Moore & CO. raised its stake in Nutrien by 2.2% in the third quarter. Smith Moore & CO. now owns 7,642 shares of the company’s stock worth $449,000 after buying an additional 168 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in Nutrien by 21.8% in the fourth quarter. EverSource Wealth Advisors LLC now owns 983 shares of the company’s stock worth $61,000 after buying an additional 176 shares in the last quarter. Finally, Cascade Investment Advisors Inc. increased its position in shares of Nutrien by 0.6% during the third quarter. Cascade Investment Advisors Inc. now owns 30,855 shares of the company’s stock worth $1,811,000 after purchasing an additional 185 shares in the last quarter. 63.10% of the stock is currently owned by hedge funds and other institutional investors.

Nutrien Company Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.